Neuphoria Therapeutics Inc. (NEUP)

Nasdaq · Pharmaceutical Preparations · Inc. C3

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 1 signal for Neuphoria Therapeutics Inc.. Most notable: 2026-07-24: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing material agreement
  4. Insider purchase
    Lynx1 Capital Management LP (ten_percent_owner) bought $3.3M of stock

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2025-10-21Lynx1 Capital Management LPten percent ownerP639,1105.14$3,285,025

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings